Thyroid Cancer: From Pathophysiology to Novel Therapies
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 20 March 2025 | Viewed by 35
Special Issue Editor
Special Issue Information
Dear Colleagues,
Thyroid cancer is one of the most common endocrine malignancies, which arises from abnormal cell growth in the thyroid gland. The causes of its occurrence and development are multifaceted and involve factors such as genetic mutations, epigenetic alterations and the environment. Understanding these underlying mechanisms is crucial for developing novel therapies. Current treatment options may include surgery, radiation therapy including radioactive iodine, chemotherapy, thyroid hormone, targeted therapy, and watchful waiting. However, recent advancements in molecular biology have paved the way for novel therapies. Tyrosine kinase inhibitors (TKIs) such as sorafenib and lenvatinib have shown promise in treating advanced thyroid cancers by targeting key signaling pathways. Additionally, immunotherapies, including immune checkpoint inhibitors, are being explored to harness the patient's immune system against the cancer.
This Special Issue aims to present the latest research regarding the pathophysiology and novel therapies for thyroid cancer. Both original research articles and comprehensive reviews are welcomed.
Dr. Miklós Bodor
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- thyroid cancer
- therapies
- cell signaling
- biomarker
- kinase inhibitors
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
